Aduro Biotech | Discovering and Developing Immunotherapies.

Immunotherapy

Learn how immunotherapies harness a person’s immune system to fight diseases

STING Pathway

APRIL Pathway

Clinical Trials

Learn more about Aduro’s clinical programs

Investors

Download the 2018 Annual Report

Recent News

October 02, 2019 Aduro Biotech Announces Two Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer 34th Annual Meeting (SITC 2019)

September 30, 2019 Aduro Biotech to Present at the 2019 Cantor Global Healthcare Conference

September 04, 2019 Aduro Biotech Announces First Patient Dosed in Phase 2 Study of ADU-S100 (MIW815) in Combination with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)

Careers

Are you interested in working for a company where interactions are authentic, commitment is high and people excel together?